Literature DB >> 2578929

Marked episodic elevation of cerebrospinal fluid pressure during nocturnal sleep in patients with sleep apnea hypersomnia syndrome.

Y Sugita, S Iijima, Y Teshima, T Shimizu, N Nishimura, T Tsutsumi, H Hayashi, H Kaneda, Y Hishikawa.   

Abstract

The CSF pressure was measured continuously at the lumbar level during nocturnal sleep in 3 patients with sleep apnea hypersomnia syndrome. Nocturnal sleep was very unstable with frequent episodes of obstructive sleep apnea. When the patients were awake and relaxed in the supine position, their CSF pressure was stable and within the normal range. Episodic marked elevations of CSF pressure occurred frequently during sleep, and each elevation was preceded and accompanied by an episode of sleep apnea or hypopnea. Significant correlations were found between the duration of apneic episodes and increase of CSF pressure, and between decrease of SaO2 or TcPO2 and increase of CSF pressure. The duration of sleep apnea was longer, increase of CSF pressure was greater, and decreases of SaO2 and TcPO2 were more marked during REM sleep than during NREM sleep. It is suggested that the frequent marked episodic elevations of CSF pressure are caused by an increase in the intracranial vascular volume occurring mainly in response to transient hypercapnia and hypoxia, which are induced by pulmonary hypoventilation during the episodes of sleep apnea.

Entities:  

Mesh:

Year:  1985        PMID: 2578929     DOI: 10.1016/0013-4694(85)90033-1

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  25 in total

1.  The effect of simulated obstructive apnoea on intraocular pressure and pulsatile ocular blood flow in healthy young adults.

Authors:  P O Lundmark; G E Trope; J G Flanagan
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

2.  Impact of Obesity and Obstructive Sleep Apnea in Lateral Skull Base Cerebrospinal Fluid Leak Repair.

Authors:  Kristen L Yancey; Nauman F Manzoor; Patrick D Kelly; Robert J Yawn; Matthew O'Malley; Alejandro Rivas; David S Haynes; Marc L Bennett
Journal:  Laryngoscope       Date:  2019-11-27       Impact factor: 3.325

Review 3.  Cardiovascular function during sleep apnoeas.

Authors:  E D Vlachogianni
Journal:  Postgrad Med J       Date:  1989-02       Impact factor: 2.401

4.  Obstructive sleep apnea in idiopathic intracranial hypertension: comparison with matched population data.

Authors:  Matthew J Thurtell; Lynn Marie Trotti; Edward O Bixler; David B Rye; Donald L Bliwise; Nancy J Newman; Valérie Biousse; Beau B Bruce
Journal:  J Neurol       Date:  2013-02-15       Impact factor: 4.849

5.  CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome.

Authors:  Takashi Kanbayashi; Tohru Kodama; Hideaki Kondo; Shinsuke Satoh; Yuichi Inoue; Shigeru Chiba; Tetsuo Shimizu; Seiji Nishino
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

6.  Headaches and papilloedema in a pregnant woman with polycystic ovarian syndrome.

Authors:  Adam Morton
Journal:  Obstet Med       Date:  2011-03-01

7.  Sleep disordered breathing in children and adolescents with Chiari malformation type I.

Authors:  Anna Losurdo; Serena Dittoni; Elisa Testani; Chiara Di Blasi; Emanuele Scarano; Paolo Mariotti; Giovanna Paternoster; Concezio Di Rocco; Luca Massimi; Giacomo Della Marca
Journal:  J Clin Sleep Med       Date:  2013-04-15       Impact factor: 4.062

Review 8.  Epidemiology and risk factors for idiopathic intracranial hypertension.

Authors:  John Chen; Michael Wall
Journal:  Int Ophthalmol Clin       Date:  2014

9.  Risk factors for idiopathic intracranial hypertension in men: a case-control study.

Authors:  J Alexander Fraser; Beau B Bruce; Janet Rucker; Lisa-Ann Fraser; Edward J Atkins; Nancy J Newman; Valérie Biousse
Journal:  J Neurol Sci       Date:  2009-11-30       Impact factor: 3.181

Review 10.  Idiopathic intracranial hypertension in otolaryngology.

Authors:  Mudit Jindal; Lucinda Hiam; Ashok Raman; Darius Rejali
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-04-08       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.